MHRA

Recent news mentioning MHRA

• 2026-07-30 — Cytokinetics Announces MHRA Marketing Authorisation for MYQORZO®▼ (aficamten) and Positive Guidance from NICE for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Wales

Appears alongside

• NICE

Browse the full archive →